Bone Marrow Transplant (BMT)

What is Bone Marrow Transplant (BMT)?

A Bone Marrow Transplant (or Hematopoietic Stem Cell Transplant) replaces damaged, destroyed, or cancerous bone marrow with healthy, functional blood stem cells. Bone marrow is the spongy tissue inside bones responsible for producing red blood cells, white blood cells, and platelets. The procedure restores the body's capacity to manufacture blood cells and rebuild a healthy immune system.

Who Needs a Bone Marrow Transplant?

Stem cell transplantation is indicated for patients with severe blood disorders, bone marrow failure, or hematologic malignancies that do not respond to standard chemotherapy alone.

Key clinical indicators include:

• Diagnosis of blood cancers such as Acute/Chronic Leukemia, Multiple Myeloma, or Lymphoma.
• Severe Non-Malignant Conditions like Aplastic Anemia, Thalassemia Major, or Sickle Cell Disease.
• Relapse of disease following primary chemotherapy or targeted immunotherapy.
• Genetic immunodeficiency disorders or metabolic storage diseases.

Types of Bone Marrow Transplant

• Autologous BMT: Uses the patient's own stem cells, harvested prior to high-dose chemotherapy or radiation.
• Allogeneic BMT: Uses stem cells harvested from a matched donor (related HLA-matched sibling or fully matched unrelated donor).
• Haploidentical BMT: An allogeneic transplant utilizing a half-matched donor (such as a parent or child).
• Umbilical Cord Blood Transplant: Uses stem cells collected from umbilical cord blood post-birth.

Benefits of Bone Marrow Transplant

1. Potential complete cure for otherwise fatal blood malignancies and severe aplastic anemias.
2. Replaces defective genetic stem cells with healthy donor cells (Graft-versus-Leukemia effect).
3. Restores normal immune system function and blood cell manufacturing capabilities.
4. Allows high-dose chemotherapy regimens that would otherwise permanently damage bone marrow.

What to Expect Before Surgery?

Preparation for a stem cell transplant is an extensive process spanning several weeks:

• Donor Matching & Evaluation: High-resolution HLA typing to find a fully matched related or unrelated donor.
• Pre-Transplant Workup: Organ function assessments including echocardiogram, pulmonary function tests, and infectious disease screening.
• Central Line Placement: Insertion of a Hickman catheter or PICC line for frequent blood draws, medications, and stem cell infusion.
• Conditioning Regimen: 5-7 days of high-dose chemotherapy or total body irradiation (TBI) in a HEPA-filtered isolation room.

Complete Procedure

The transplantation process is non-surgical and involves the following steps:

1. Placement in a sterile, positive-pressure HEPA-filtered bone marrow transplant isolation unit.
2. Completion of the conditioning chemotherapy/radiotherapy regimen (Day -7 to Day -1).
3. Infusion of healthy stem cells through the central venous catheter (Day 0), similar to a standard blood transfusion.
4. Engraftment monitoring over the subsequent 10 to 20 days while stem cells migrate to the bone marrow space.
5. Supportive therapy including growth factors, blood/platelet transfusions, and prophylactic anti-infective medications.
6. Gradual recovery of blood counts (white blood cells, ANC, and platelets).

What to Expect During Surgery?

Because stem cells are infused intravenously rather than implanted surgically, there is no surgical incision or general anesthesia involved on transplant day. Patients remain awake in their private, sterile isolation room. Vitals and allergic response symptoms are continuously monitored throughout the infusion.

Autologous vs Allogeneic BMT

Success Rate and Safety

BMT success rates range from 60% to 85% for non-malignant conditions (like Thalassemia) and 50% to 75% for hematologic malignancies depending on stage, donor match, and patient age.

Bone Marrow Transplant Cost Estimate

Disclaimer: Costs depend on conditioning drugs used, donor acquisition fees, duration of ICU/isolation stay, and management of post-transplant complications.

Recovery Guide & Post-Operative Care

Recovery Timeline

• Days 0-30: Initial engraftment phase in isolation; high risk of neutropenic fever and infection.
• Months 1-3: Outpatient monitoring; gradual immunity rebuilding; regular blood work twice weekly.
• Months 3-6: Resumption of light daily activities; strict dietary hygiene (neutropenic diet).
• Months 6-12+: Re-vaccination schedule begins; full recovery and return to work for most patients.

Post-Op Precautions & Care

• Infection Prevention: Wear N95 masks, avoid public gatherings, and maintain strict personal hygiene.
• Immunosuppressant Adherence: Take prescribed anti-rejection and anti-fungal/viral medications on exact schedules.
• Dietary Restrictions: Eat freshly cooked food only; avoid raw salads, unpasteurized dairy, and street food.
• GVHD Monitoring: Report skin rash, yellowing of skin/eyes, or severe watery diarrhea immediately to the transplant team.